{
  "ticker": "LLY",
  "target_date": "2025-11-07",
  "actual_date": "2025-11-07",
  "collected_at": "2025-12-08T12:30:27.382095",
  "price": {
    "open": 929.8,
    "high": 930.63,
    "low": 899.58,
    "close": 923.0144653320312,
    "volume": 4373400,
    "change_1d_pct": -1.39,
    "change_7d_pct": 13.62,
    "change_30d_pct": 27.58
  },
  "technicals": {
    "rsi_14": 81.01,
    "sma_20": 844.08,
    "sma_50": 798.95,
    "macd": 34.728,
    "macd_signal": 25.583,
    "macd_histogram": 9.145,
    "bb_upper": 935.72,
    "bb_lower": 752.44,
    "price_vs_sma20_pct": 9.35,
    "price_vs_sma50_pct": 15.53,
    "volume_ratio": 1.19
  },
  "fundamentals": {
    "market_cap": 892472000512,
    "pe_ratio": 48.777805,
    "forward_pe": 43.934467,
    "price_to_book": 37.483246,
    "price_to_sales": 15.019774,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.47,
    "pct_from_52w_low": 59.6
  },
  "macro": {
    "spy": {
      "price": 670.97,
      "change_1d_pct": 0.1,
      "change_7d_pct": -1.3
    },
    "vix": {
      "level": 19.08,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.09
    },
    "dollar_index": {
      "level": 99.6
    },
    "gold": {
      "price": 3999.4
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Why Nvidia (NVDA) Stock Is Falling Today",
      "source": "Yahoo",
      "datetime": 1762539060,
      "summary": "Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) fell 4.1% in the afternoon session after the stock retreated amid renewed concerns about stretched valuations in the AI space and geopolitical concerns as the U.S. government reportedly moved to block the company from selling even its",
      "url": "https://finnhub.io/api/news?id=08d73bd1029d824e0df38118dec6cf25595da21d6c26a5574d05a5d88e228d1d"
    },
    {
      "headline": "Health Care Roundup: Market Talk",
      "source": "DowJones",
      "datetime": 1762534560,
      "summary": "Health Care Roundup: Market Talk",
      "url": "https://finnhub.io/api/news?id=cb6e4294669b96c260dbcf2d0050088834e59ac538a5cf48c14da54c3f1d8f51"
    },
    {
      "headline": "LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs",
      "source": "Yahoo",
      "datetime": 1762530240,
      "summary": "Lilly's Mounjaro and Zepbound continue to power growth as new launches boost momentum amid rising obesity competition.",
      "url": "https://finnhub.io/api/news?id=6e94b7b163dc5287f2c7945ac10b1ded9531f218625c6ec38d9628967f18a2ec"
    },
    {
      "headline": "Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk",
      "source": "CNBC",
      "datetime": 1762529370,
      "summary": "Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.",
      "url": "https://finnhub.io/api/news?id=94aca79497af079c36c1ee95e6334507f2980bc5f3e4c07cc1a4b56eca57cce2"
    },
    {
      "headline": "Zepbound Maker Eli Lilly Stock Weighs In On Trump Weight-Loss Drug Deal",
      "source": "Yahoo",
      "datetime": 1762529363,
      "summary": "Eli Lilly stock is nearing a buy point and a high. The White House signed a historic deal to slash obesity drug prices.",
      "url": "https://finnhub.io/api/news?id=a64c8ba4a545cfb8073376d131328b2d3c21a9b3688214bddff66be2f4cb8092"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-06",
      "description": "xslF345X05/form4-11062025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000055/xslF345X05/form4-11062025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-06",
      "description": "xslF345X05/form4-11062025_041102.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000054/xslF345X05/form4-11062025_041102.xml"
    },
    {
      "form": "4",
      "date": "2025-11-05",
      "description": "xslF345X05/form4-11052025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000051/xslF345X05/form4-11052025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-04",
      "description": "xslF345X05/form4-11042025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000049/xslF345X05/form4-11042025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-03",
      "description": "xslF345X05/form4-11032025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000045/xslF345X05/form4-11032025_041101.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}